Covid Antibody Drugs Shown To Cut Risk Of Death, Serious Illness In Trials
New studies show over 80% lower risk of hospitalization and death when covid patients are given Ely Lilly's monoclonal antibody drugs. Meanwhile, convalescent plasma is deemed ineffective in different studies.